Regencell Bioscience Holdings (RGC) Shares Outstanding (2020 - 2025)

Regencell Bioscience Holdings (RGC) posted Shares Outstanding (Entity) of $494.5 million for Q2 2023, up 30.13% on a QoQ basis from $380.0 million in Q2 2020.

Regencell Bioscience Holdings (RGC) Shares Outstanding (2020 - 2025) Analysis & Trends

Regencell Bioscience Holdings' Shares Outstanding (Entity) history runs 2 years deep, the most recent figure standing at $494.5 million for Q2 2023.

  • Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $494.5 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $494.5 million (changed N/A YoY) and the FY2023 annual result came in at $494.5 million, changed N/A from the prior year.
  • Shares Outstanding (Entity) was $494.5 million for Q2 2023 at Regencell Bioscience Holdings, up from $380.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $494.5 million in Q2 2023 and bottomed at $380.0 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Regencell Bioscience Holdings 2.78 Bn 2.78 Bn - 494.49 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 494.49 Mn
Jun 30, 2025 494.49 Mn
Jun 30, 2024 494.49 Mn
Jun 30, 2023 494.49 Mn
Jun 30, 2022 486.62 Mn
Jun 30, 2021 380.00 Mn
Jun 30, 2020 380.00 Mn